AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $12.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$12.5M netNet selling
- CongressSTOCK Act, last 180 days
- +$1K to +$15K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $64.58
- 52-wk high
- $88.31
- High
- $66.41
- 52-wk low
- $54.30
- Low
- $64.25
- Prev close
- $65.64
- Mkt cap
- $9.13B
- Volume
- 2.55M
- Fwd P/E
- 117.7x
- Beta
- 0.36
- P/S
- 134.8x
- P/B
- 60.3x
- Profit margin
- +0.0%
- Op margin
- -626.0%
- ROE
- -572.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CYTK filings
Are insiders buying or selling Cytokinetics Inc (CYTK) stock?
Net selling: insiders sold $12.5M and bought $0 of CYTK stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $12.5M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Blum, Robert I (President & CEO), who sold $10.2M. The latest filing was on Sep 28, 2026.
Which members of Congress have traded CYTK recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Jun 30, 2026, disclosed 2 days later. In total, 1 member disclosed 1 CYTK trade with trade dates in the last 180 days, filed a median 2 days after trading.
How current is this CYTK smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- P7
Point72
$94.0M
added
- SU
Susquehanna
$72.7M
added
Sells/Trims (1)
- FM
FMR LLC
$278.1M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in CYTK right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 8.0% above what analysts expected.
Earnings per share
-$1.63 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 29, 2026
EPS expected
-$1.65 to -$1.10
Revenue expected
20 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.9M | $17.8M | $19.4M | $31.9M |
| Cost of what it sold | $2.7M | $2.9M | $2.4M | $2.7M |
| Gross profit | -$743.0K | $14.9M | $17.0M | $29.2M |
| What it spent | ||||
| Research and development | $99.2M | $101.5M | $95.5M | $97.8M |
| Sales and admin | $69.5M | $91.7M | $104.9M | $104.4M |
| Other operating costs | -$2.7M | — | — | $2.9M |
| Total operating expenses | $166.0M | $193.3M | $200.6M | $205.1M |
| What was left | ||||
| Operating profit | -$166.8M | -$178.4M | -$183.6M | -$175.9M |
| Interest on debt | $26.3M | $30.3M | $33.3M | $34.8M |
| Profit before tax | -$306.2M | -$183.0M | -$206.0M | -$198.8M |
| Net profit | -$306.2M | -$183.0M | -$206.0M | -$198.8M |
| EBITDA | -$277.2M | -$180.4M | -$169.3M | -$191.8M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace